Funding · effective August 31, 2026
How we pay for this
Reading costs you nothing. Some links pay us. Here is exactly which ones, where they sit, and what the money is not allowed to touch.
The short version
When you follow one of our partner links and start care with that company, it pays us a commission. You pay nothing extra for arriving through us, and the price you see is the price you would see going straight to them. Nobody pays us to be listed, to be listed first, or to be described a particular way.
Who pays us, and for what
Those partner links run through Katalys, an affiliate network that sits between publishers like us and the telehealth companies that advertise through it. Katalys records that a click came from this site, the company reports back when that click turns into a customer, and a commission is paid. A number of cash-pay telehealth companies are wired up this way and others are not, and which is which changes as programs open and close. Rather than print a roster here that goes stale, every page carrying a paid link says so on that page, beside the link itself.
Every one of them is a cash-pay telehealth seller. None of them is an insurer, and no insurer, plan administrator or government program pays this site anything. We have no advertising sales, no sponsorships, no sponsored posts, and no paid newsletter placements, because there is no newsletter. If a page here mentions an insurer, a state agency or a federal rule, no money is attached to it at all.
What it costs you
Nothing. A partner link adds tracking parameters to the destination address so the referral can be credited. It does not change the price you are quoted, the plan you are offered, or the terms you are given. See the privacy page for exactly what those parameters contain, which is information about us, not about you.
Where the partner links appear
In three forms, all labeled. The denial fork is a single block listing the twenty-one companies with a short dated note about each; you will find it on the denial page, the plan pages, the procedure pages and every state page, always at the foot of the page and after the appeal routes. On a state page it shows six of them, in an order that differs from state to state, and links to the full list. Every list and card here rotates on a fixed clock: every eight hours each one moves on to the next company, so every partner gets the same turn in every spot, and none pays to be first. The second is one card on a state page or an answer page, showing a single company at a time. On a wide screen it sits at the top of the right-hand column, beside the coverage answer rather than after it; on a phone it moves into the single reading column and lands below the whole coverage answer. The third is that same card as a slide-in in the bottom-right corner, which appears once you have read part of the way down one of these pages and not before; you can close it, and closing it means you will not see it again for a week. Each names the commission in full inside the card, under the button, and carries our own advice to work the appeal before paying cash. None of the three changes what the coverage pages say, and the appeal routes are free.
On the denial page
If you are denied carries it below the appeal routes, the deadlines and the manufacturer program information.
On plan pages
Medicare Part D, Medicaid and employer plans each carry it under that plan's coverage rules and appeal path.
On state pages
A state page carries the card in the right-hand column, at the top of that column on a wide screen and below the whole coverage answer on a phone, and the shorter block at the foot of the page. A state publishes here only once it has enough sourced facts to be worth reading.
On answer pages
Each answer carries the card in the right-hand column. A reader who is there to understand a denial is one of the people most likely to end up paying cash, so the card names one company and our own advice to appeal first sits inside it.
On procedure pages
Each step-by-step procedure carries it after the steps, the phone script and the sources those steps rest on.
Wherever it appears, the block says in its own body that those companies pay us — the state card names the commission in full in its own body, in the same short block as the button and visible without scrolling. You should never have to find this page to learn that.
Where they never appear
Not in the footer. Not in the navigation at the top. Not inside a sentence of coverage text, dressed up as a source. Not on the coverage matrix where you are comparing states, and not on the pages you are reading right now. And never above the appeal information on any page.
Why the paid block always sits below the appeal
Because of when you get here. Most readers who reach the denial fork have just been told no by their plan, which is the moment they are most likely to be sold something badly. The order of the page is the safeguard: you get the free route in full, with its deadlines and its sources, before you are shown anything anyone paid for.
That order costs us money on purpose. A reader who wins an appeal never clicks a partner link, and winning the appeal is still the first thing we tell you to try.
Cash-pay is the fallback, not the bargain
Say this part plainly, because a lot of sites do not. Paying cash means paying the entire cost yourself. A covered prescription, with your plan paying its share, is almost always cheaper than any cash-pay program on this list, including the ones advertising a flat monthly rate.
Use the cash route in two situations. One, coverage is genuinely exhausted and the appeal has run out. Two, you need to start now while an appeal is still pending. If neither describes you, work the appeal first. The routes are on the denial page and the procedure pages.
The notes beside each company were read from that company's own site in August 2026 and change often. They are dated observations, not quotes we can guarantee are current, and the page a link opens can differ from the marketing page a price was read on. Check the number yourself before you pay anything.
What the money does not buy
It does not change a coverage fact. Whether your plan covers a drug is your plan's decision, published in your plan's own documents, and we report it from the payer's policy with the date we read it. If a payer publishes nothing, we say so instead of guessing.
It does not change a deadline. Appeal windows come from regulations and from the notice you were sent, and no commission moves one by a day.
It does not change a source. Every fact links to the document it came from, and you can check every one of them without ever touching a paid link.
It does not buy placement or ranking. No company pays extra to appear higher, and there is no unpaid list that the paying ones are ranked ahead of. What we write about a partner is written the same way we would write it if the program did not exist, including the unflattering parts. One partner's note records a lander that has shown a different price than the one advertised, and it stays there precisely because the commission is not allowed to remove it.
It does not buy silence about a competitor, and it does not decide which states, plans or procedures get covered. Those follow what readers need, not what pays.
The appeal routes are free, and we will keep saying so
An internal appeal to your plan costs nothing. External review by an independent reviewer costs nothing or close to it, though a few state processes allow a small filing fee that is refunded if you win. A Medicare coverage determination and the appeal levels above it cost nothing. A Medicaid fair hearing costs nothing, and most states run a free ombudsman, hearing office or legal aid line that will help you file. Your denial notice states which of these applies to you. Nobody pays us to tell you any of it, and it is the first thing on the page.
What we are
American GLP is an independent publisher. We are not a pharmacy, an insurer, a telehealth company, a prescriber, or a law firm, and we are not affiliated with any drug manufacturer, any insurer, or any government program. Our relationship with the twenty-one companies above is an ordinary affiliate agreement and nothing more. Read the terms for what that means, and the medical disclaimer for what we cannot tell you.
This disclosure exists to satisfy the Federal Trade Commission's rules on endorsements and material connections. It also exists because you deserve to know who is paying before you decide what to trust.
How to report an error
Send it to desk@americanglp.org
Write to desk@americanglp.org. You do not need to be polite about it and you do not need to explain who you are.
Name the page and quote the sentence
Paste the address of the page and the exact wording that is wrong. That is faster than describing it, and it removes any doubt about which line you mean.
Tell us what it should say, and where you saw that
A link to the payer policy, the state manual, the regulation or the notice beats an assertion. We check the source, not the claim.
Leave your health information out of it
Do not send a copy of your denial letter, your member ID, or your prescriptions. Describe the rule, not your case.
Watch the date on the page
When we fix something, the read date on that fact moves and the page byline moves with it. A correction to a deadline is handled first, because a wrong deadline is the one error here that can cost you a right.